NCT02009501View on ClinicalTrials.gov

V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2015

Conditions
Lower Extremity Wound InfectedVenous Stasis Ulcers
Interventions
DEVICE

VAC VeraFlo with Dakins Instillation

VAC VeraFlo with Dakins instillation will be placed in the operating room after surgical debridement. Biopsies will be obtained prior to surgical debridement, after surgical debridement, on day 4, and on day 7.

DEVICE

VAC Ulta Therapy

VAC ULTA will be placed in the operating room after surgical debridement. Biopsies will be obtained prior to surgical debridement, after surgical debridement, on day 4, and on day 7.

Trial Locations (1)

10025

St. Luke's-Roosevelt Hospital Center, New York

All Listed Sponsors
collaborator

Kinetic Concepts, Inc.

INDUSTRY

lead

St. Luke's-Roosevelt Hospital Center

OTHER

NCT02009501 - V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds | Biotech Hunter | Biotech Hunter